{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:01:29Z","timestamp":1790978489994,"version":"4.1.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T00:00:00Z","timestamp":1343433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T00:00:00Z","timestamp":1343433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00281-012-0328-6","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T13:31:25Z","timestamp":1343395885000},"page":"73-85","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Autoimmune manifestations in viral hepatitis"],"prefix":"10.1007","volume":"35","author":[{"given":"Diego","family":"Vergani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgina","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,28]]},"reference":[{"key":"328_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1600-065X.1996.tb00909.x","volume":"152","author":"P Aichele","year":"1996","unstructured":"Aichele P, Bachmann MF, Hengartner H, Zinkernagel RM (1996) Immunopathology or organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 152:21\u201345","journal-title":"Immunol Rev"},{"issue":"17","key":"328_CR2","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2174\/138161208784746824","volume":"14","author":"S Ferri","year":"2008","unstructured":"Ferri S, Muratori L, Lenzi M, Granito A, Bianchi FB, Vergani D (2008) HCV and autoimmunity. Curr Pharm Des 14(17):1678\u20131685","journal-title":"Curr Pharm Des"},{"issue":"1","key":"328_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","volume":"39","author":"AL Zignego","year":"2007","unstructured":"Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39(1):2\u201317. doi:10.1016\/j.dld.2006.06.008","journal-title":"Dig Liver Dis"},{"issue":"2","key":"328_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.autrev.2008.07.012","volume":"8","author":"AL Zignego","year":"2008","unstructured":"Zignego AL, Piluso A, Giannini C (2008) HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation. Autoimmun Rev 8(2):107\u2013111. doi:10.1016\/j.autrev.2008.07.012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"328_CR5","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1365-2249.1998.00574.x","volume":"112","author":"GV Gregorio","year":"1998","unstructured":"Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D (1998) Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 112(3):471\u2013476","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"328_CR6","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/gut.45.3.435","volume":"45","author":"M Lenzi","year":"1999","unstructured":"Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, Cassani F, Bianchi FB, Tiribelli C (1999) Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case\u2013control study of the Dionysos cohort. Gut 45(3):435\u2013441","journal-title":"Gut"},{"issue":"10","key":"328_CR7","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1086\/379018","volume":"37","author":"P Muratori","year":"2003","unstructured":"Muratori P, Muratori L, Verucchi G, Attard L, Bianchi FB, Lenzi M (2003) Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 37(10):1320\u20131326. doi:10.1086\/379018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"328_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0016-5085(95)90020-9","volume":"108","author":"AJ Czaja","year":"1995","unstructured":"Czaja AJ, Carpenter HA, Santrach PJ, Moore SB (1995) Immunologic features and HLA associations in chronic viral hepatitis. Gastroenterology 108(1):157\u2013164","journal-title":"Gastroenterology"},{"issue":"1","key":"328_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1034\/j.1399-0039.2002.590106.x","volume":"59","author":"SJ Hwang","year":"2002","unstructured":"Hwang SJ, Chu CW, Huang DF, Lan KH, Chang FY, Lee SD (2002) Genetic predispositions for the presence of cryoglobulinemia and serum autoantibodies in Chinese patients with chronic hepatitis C. Tissue Antigens 59(1):31\u201337","journal-title":"Tissue Antigens"},{"issue":"5","key":"328_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1136\/jcp.29.5.403","volume":"29","author":"GF Bottazzo","year":"1976","unstructured":"Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U (1976) Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 29(5):403\u2013410","journal-title":"J Clin Pathol"},{"issue":"7","key":"328_CR11","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/jcp.38.7.801","volume":"38","author":"F Cassani","year":"1985","unstructured":"Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E (1985) Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 38(7):801\u2013805","journal-title":"J Clin Pathol"},{"issue":"4","key":"328_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jhep.2004.08.002","volume":"41","author":"D Vergani","year":"2004","unstructured":"Vergani D, Alvarez F, Bianchi FB, Cancado EL, Mackay IR, Manns MP, Nishioka M, Penner E (2004) Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41(4):677\u2013683. doi:10.1016\/j.jhep.2004.08.002","journal-title":"J Hepatol"},{"issue":"5","key":"328_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.36.5.749","volume":"36","author":"M Lenzi","year":"1995","unstructured":"Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F, Bianchi FB (1995) Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection. Gut 36(5):749\u2013754","journal-title":"Gut"},{"issue":"2","key":"328_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaut.2003.11.001","volume":"22","author":"K Beland","year":"2004","unstructured":"Beland K, Lapierre P, Marceau G, Alvarez F (2004) Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection. J Autoimmun 22(2):159\u2013166. doi:10.1016\/j.jaut.2003.11.001S0896841103001793","journal-title":"J Autoimmun"},{"key":"328_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1740-2557-4-2","volume":"4","author":"EI Rigopoulou","year":"2007","unstructured":"Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN (2007) Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmune Dis 4:2. doi:10.1186\/1740-2557-4-2","journal-title":"J Autoimmune Dis"},{"issue":"5","key":"328_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1590-8658(00)80266-2","volume":"32","author":"DP Bogdanos","year":"2000","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D (2000) Virus, liver and autoimmunity. Dig Liver Dis 32(5):440\u2013446","journal-title":"Dig Liver Dis"},{"issue":"10","key":"328_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1086\/383578","volume":"38","author":"DP Bogdanos","year":"2004","unstructured":"Bogdanos DP, Mieli-Vergani G, Vergani D (2004) Non-organ-specific autoantibodies in children with chronic hepatitis C virus infection. Clin Infect Dis 38(10):1505. doi:10.1086\/383578, author reply 1505\u20131506","journal-title":"Clin Infect Dis"},{"issue":"3","key":"328_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/hep.510260305","volume":"26","author":"F Cassani","year":"1997","unstructured":"Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB (1997) Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile [see comments]. Hepatology 26(3):561\u2013566","journal-title":"Hepatology"},{"issue":"3","key":"328_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2893.2004.00489.x","volume":"11","author":"T Stroffolini","year":"2004","unstructured":"Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, Pasquale G, Venezia G, Craxi A, Almasio P (2004) Does an \u2018autoimmune\u2019 profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 11(3):257\u2013262. doi:10.1111\/j.1365-2893.2004.00489.x","journal-title":"J Viral Hepat"},{"key":"328_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2334-4-4","volume":"4","author":"HE Wasmuth","year":"2004","unstructured":"Wasmuth HE, Stolte C, Geier A, Dietrich CG, Gartung C, Lorenzen J, Matern S, Lammert F (2004) The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 4:4. doi:10.1186\/1471-2334-4-41471-2334-4-4","journal-title":"BMC Infect Dis"},{"issue":"6","key":"328_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1002\/hep.1840200611","volume":"20","author":"S Bellentani","year":"1994","unstructured":"Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, Cristianini G (1994) Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos study. Hepatology 20(6):1442\u20131449","journal-title":"Hepatology"},{"issue":"6","key":"328_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/gut.44.6.874","volume":"44","author":"S Bellentani","year":"1999","unstructured":"Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Croce LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C (1999) Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study. Gut 44(6):874\u2013880","journal-title":"Gut"},{"issue":"4","key":"328_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0168-8278(96)80201-7","volume":"25","author":"F Giostra","year":"1996","unstructured":"Giostra F, Manzin A, Lenzi M, Francesconi R, Solforosi L, Manotti P, Muratori L, Zauli D, Clementi M, Bianchi FB (1996) Low hepatitis C viremia levels in patients with anti-liver\/kidney microsomal antibody type 1 positive chronic hepatitis. J Hepatol 25(4):433\u2013438","journal-title":"J Hepatol"},{"issue":"2","key":"328_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0168-8278(05)80395-2","volume":"21","author":"L Muratori","year":"1994","unstructured":"Muratori L, Lenzi M, Cataleta M, Giostra F, Cassani F, Ballardini G, Zauli D, Bianchi FB (1994) Interferon therapy in liver\/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol 21(2):199\u2013203","journal-title":"J Hepatol"},{"issue":"5","key":"328_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/hep.1840220506","volume":"22","author":"L Todros","year":"1995","unstructured":"Todros L, Saracco G, Durazzo M, Abate ML, Touscoz G, Scaglione L, Verme G, Rizzetto M (1995) Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver\u2013kidney microsomes. Hepatology 22(5):1374\u20131378","journal-title":"Hepatology"},{"issue":"6","key":"328_CR26","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2009.02.020","volume":"50","author":"S Ferri","year":"2009","unstructured":"Ferri S, Muratori L, Quarneti C, Muratori P, Menichella R, Pappas G, Granito A, Ballardini G, Bianchi FB, Lenzi M (2009) Clinical features and effect of antiviral therapy on anti-liver\/kidney microsomal antibody type 1 positive chronic hepatitis C. J Hepatol 50(6):1093\u20131101. doi:10.1016\/j.jhep.2009.02.020","journal-title":"J Hepatol"},{"issue":"3","key":"328_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hep.1840160304","volume":"16","author":"F Lunel","year":"1992","unstructured":"Lunel F, Abuaf N, Frangeul L, Grippon P, Perrin M, Le Coz Y, Valla D, Borotto E, Yamamoto AM, Huraux JM et al (1992) Liver\/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 16(3):630\u2013636","journal-title":"Hepatology"},{"issue":"8788","key":"328_CR28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0140-6736(92)91332-3","volume":"339","author":"G Michel","year":"1992","unstructured":"Michel G, Ritter A, Gerken G, Meyer zum Buschenfelde KH, Decker R, Manns MP (1992) Anti-GOR and hepatitis C virus in autoimmune liver diseases [see comments]. Lancet 339(8788):267\u2013269","journal-title":"Lancet"},{"issue":"8836","key":"328_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0140-6736(93)92541-Z","volume":"341","author":"Y Ma","year":"1993","unstructured":"Ma Y, Peakman M, Lenzi M, Gaken J, Thomas MG, Farzaneh F, Ballardini G, Cassani F, Mieli-Vergani G, Bianchi FB et al (1993) Case against subclassification of type II autoimmune chronic active hepatitis. Lancet 341(8836):60","journal-title":"Lancet"},{"issue":"1","key":"328_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2249.1994.tb06585.x","volume":"97","author":"Y Ma","year":"1994","unstructured":"Ma Y, Peakman M, Lobo-Yeo A, Wen L, Lenzi M, Gaken J, Farzaneh F, Mieli-Vergani G, Bianchi FB, Vergani D (1994) Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection. Clin Exp Immunol 97(1):94\u201399","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"328_CR31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.169.1.277","volume":"169","author":"Y Ma","year":"2002","unstructured":"Ma Y, Thomas MG, Okamoto M, Bogdanos DP, Nagl S, Kerkar N, Lopes AR, Muratori L, Lenzi M, Bianchi FB, Mieli-Vergani G, Vergani D (2002) Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule. J Immunol 169(1):277\u2013285","journal-title":"J Immunol"},{"issue":"11","key":"328_CR32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1365-2362.1994.tb01077.x","volume":"24","author":"C Ferri","year":"1994","unstructured":"Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, Lombardini F, Greco F, Pasero G, Bombardieri S et al (1994) Hepatitis C virus infection in non-Hodgkin\u2019s B-cell lymphoma complicating mixed cryoglobulinaemia. Eur J Clin Invest 24(11):781\u2013784","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"328_CR33","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0168-8278(99)80239-6","volume":"31","author":"AL Zignego","year":"1999","unstructured":"Zignego AL, Brechot C (1999) Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 31(2):369\u2013376","journal-title":"J Hepatol"},{"issue":"11","key":"328_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1056\/NEJM199403173301104","volume":"330","author":"R Misiani","year":"1994","unstructured":"Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, Zilio P, Vernocchi A, Massazza M, Vendramin G et al (1994) Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330(11):751\u2013756. doi:10.1056\/NEJM199403173301104","journal-title":"N Engl J Med"},{"issue":"6","key":"328_CR35","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/hep.21190","volume":"43","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, Piette JC, Marcellin P, Cacoub P (2006) Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 43(6):1337\u20131345. doi:10.1002\/hep.21190","journal-title":"Hepatology"},{"issue":"21","key":"328_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJM199211193272111","volume":"327","author":"KJ Bloch","year":"1992","unstructured":"Bloch KJ (1992) Cryoglobulinemia and hepatitis C virus. N Engl J Med 327(21):1521\u20131522. doi:10.1056\/NEJM199211193272111","journal-title":"N Engl J Med"},{"issue":"11","key":"328_CR37","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/art.1780401113","volume":"40","author":"V Agnello","year":"1997","unstructured":"Agnello V, Abel G (1997) Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 40(11):2007\u20132015. doi:10.1002\/1529-0131(199711)40:11<2007::AID-ART13>3.0.CO;2-8","journal-title":"Arthritis Rheum"},{"issue":"3","key":"328_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/jmv.1890440310","volume":"44","author":"M Willems","year":"1994","unstructured":"Willems M, Sheng L, Roskams T, Ramdani B, Doutrelepont JM, Nevens F, Durez P, Treille S, Adler M, Desmet V et al (1994) Hepatitis C virus and its genotypes in patients suffering from chronic hepatitis C with or without a cryoglobulinemia-related syndrome. J Med Virol 44(3):266\u2013271","journal-title":"J Med Virol"},{"issue":"11","key":"328_CR39","first-page":"805","volume":"88","author":"RA Sinico","year":"1995","unstructured":"Sinico RA, Ribero ML, Fornasieri A, Renoldi P, Zhou J, Fasola M, Portera G, Arrigo G, Gibelli A, D\u2019Amico G et al (1995) Hepatitis C virus genotype in patients with essential mixed cryoglobulinaemia. QJM 88(11):805\u2013810","journal-title":"QJM"},{"issue":"4","key":"328_CR40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/jmv.10435","volume":"70","author":"A Gad","year":"2003","unstructured":"Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K (2003) Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence. J Med Virol 70(4):594\u2013599. doi:10.1002\/jmv.10435","journal-title":"J Med Virol"},{"issue":"9","key":"328_CR41","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1046\/j.1365-2036.1999.00581.x","volume":"13","author":"JL Calleja","year":"1999","unstructured":"Calleja JL, Albillos A, Moreno-Otero R, Rossi I, Cacho G, Domper F, Yebra M, Escartin P (1999) Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia. Aliment Pharmacol Ther 13(9):1179\u20131186","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"328_CR42","first-page":"2172","volume":"27","author":"E Zuckerman","year":"2000","unstructured":"Zuckerman E, Keren D, Slobodin G, Rosner I, Rozenbaum M, Toubi E, Sabo E, Tsykounov I, Naschitz JE, Yeshurun D (2000) Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 27(9):2172\u20132178","journal-title":"J Rheumatol"},{"issue":"12","key":"328_CR43","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1002\/art.10699","volume":"46","author":"P Cacoub","year":"2002","unstructured":"Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46(12):3317\u20133326. doi:10.1002\/art.10699","journal-title":"Arthritis Rheum"},{"issue":"8","key":"328_CR44","first-page":"1775","volume":"30","author":"C Mazzaro","year":"2003","unstructured":"Mazzaro C, Zorat F, Comar C, Nascimben F, Bianchini D, Baracetti S, Donada C, Donadon V, Pozzato G (2003) Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon. J Rheumatol 30(8):1775\u20131781","journal-title":"J Rheumatol"},{"issue":"4","key":"328_CR45","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","volume":"43","author":"L Alric","year":"2004","unstructured":"Alric L, Plaisier E, Thebault S, Peron JM, Rostaing L, Pourrat J, Ronco P, Piette JC, Cacoub P (2004) Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 43(4):617\u2013623","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"328_CR46","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.20958","volume":"52","author":"P Cacoub","year":"2005","unstructured":"Cacoub P, Saadoun D, Limal N, Sene D, Lidove O, Piette JC (2005) PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52(3):911\u2013915. doi:10.1002\/art.20958","journal-title":"Arthritis Rheum"},{"issue":"5","key":"328_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","volume":"42","author":"C Mazzaro","year":"2005","unstructured":"Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, Carniello G, Virgolini L, Tirelli U, Pozzato G (2005) Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 42(5):632\u2013638. doi:10.1016\/j.jhep.2004.10.031","journal-title":"J Hepatol"},{"issue":"8","key":"328_CR48","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.autrev.2011.01.008","volume":"10","author":"M Pietrogrande","year":"2011","unstructured":"Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M (2011) Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev 10(8):444\u2013454. doi:10.1016\/j.autrev.2011.01.008","journal-title":"Autoimmun Rev"},{"issue":"11","key":"328_CR49","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.autrev.2011.04.033","volume":"10","author":"M Visentini","year":"2011","unstructured":"Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M (2011) A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection. Autoimmun Rev 10(11):714\u2013719. doi:10.1016\/j.autrev.2011.04.033","journal-title":"Autoimmun Rev"},{"issue":"3","key":"328_CR50","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0272-6386(12)70152-X","volume":"22","author":"R Davda","year":"1993","unstructured":"Davda R, Peterson J, Weiner R, Croker B, Lau JY (1993) Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 22(3):452\u2013455","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"328_CR51","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ki.1994.393","volume":"46","author":"RJ Johnson","year":"1994","unstructured":"Johnson RJ, Willson R, Yamabe H, Couser W, Alpers CE, Wener MH, Davis C, Gretch DR (1994) Renal manifestations of hepatitis C virus infection. Kidney Int 46(5):1255\u20131263","journal-title":"Kidney Int"},{"issue":"3","key":"328_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0002-9343(99)00014-5","volume":"106","author":"L Daghestani","year":"1999","unstructured":"Daghestani L, Pomeroy C (1999) Renal manifestations of hepatitis C infection. Am J Med 106(3):347\u2013354","journal-title":"Am J Med"},{"issue":"5","key":"328_CR53","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.510250529","volume":"25","author":"D Sansonno","year":"1997","unstructured":"Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F (1997) Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 25(5):1237\u20131244. doi:10.1002\/hep.510250529","journal-title":"Hepatology"},{"issue":"8","key":"328_CR54","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S1590-8658(00)80335-7","volume":"32","author":"C Mazzaro","year":"2000","unstructured":"Mazzaro C, Panarello G, Carniello S, Faelli A, Mazzi G, Crovatto M, Baracetti S, Nascimben F, Zorat F, Pozzato G, Faccini L, Campanacci L (2000) Interferon versus steroids in patients with hepatitis C virus-associated cryoglobulinaemic glomerulonephritis. Dig Liver Dis 32(8):708\u2013715","journal-title":"Dig Liver Dis"},{"issue":"4","key":"328_CR55","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000168641","volume":"13","author":"A Pasquariello","year":"1993","unstructured":"Pasquariello A, Ferri C, Moriconi L, La Civita L, Longombardo G, Lombardini F, Greco F, Zignego AL (1993) Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus. Am J Nephrol 13(4):300\u2013304","journal-title":"Am J Nephrol"},{"issue":"7","key":"328_CR56","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-117-7-573","volume":"117","author":"R Misiani","year":"1992","unstructured":"Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G et al (1992) Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117(7):573\u2013577","journal-title":"Ann Intern Med"},{"issue":"6","key":"328_CR57","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/ki.1994.471","volume":"46","author":"RJ Johnson","year":"1994","unstructured":"Johnson RJ, Gretch DR, Couser WG, Alpers CE, Wilson J, Chung M, Hart J, Willson R (1994) Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 46(6):1700\u20131704","journal-title":"Kidney Int"},{"issue":"2","key":"328_CR58","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/ki.1995.78","volume":"47","author":"A Tarantino","year":"1995","unstructured":"Tarantino A, Campise M, Banfi G, Confalonieri R, Bucci A, Montoli A, Colasanti G, Damilano I, D'Amico G, Minetti L et al (1995) Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47(2):618\u2013623","journal-title":"Kidney Int"},{"issue":"5","key":"328_CR59","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/hep.510250529","volume":"25","author":"D Sansonno","year":"1997","unstructured":"Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F (1997) Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis [see comments]. Hepatology 25(5):1237\u20131244","journal-title":"Hepatology"},{"key":"328_CR60","doi-asserted-by":"publisher","unstructured":"Feng B, Eknoyan G, Guo ZS, Jadoul M, Rao HY, Zhang W, Wei L (2011) Effect of interferon-alpha-based antiviral therapy on hepatitis C virus-associated glomerulonephritis: a meta-analysis. Nephrol Dial Transplant. doi:10.1093\/ndt\/gfr236","DOI":"10.1093\/ndt\/gfr236"},{"issue":"12","key":"328_CR61","first-page":"1101","volume":"4","author":"S De Vita","year":"2002","unstructured":"De Vita S, Damato R, De Marchi G, Sacco S, Ferraccioli G (2002) True primary Sjogren\u2019s syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr Med Assoc J 4(12):1101\u20131105","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"328_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MCG.0b013e3182329d9c","volume":"46","author":"EC Ebert","year":"2012","unstructured":"Ebert EC (2012) Gastrointestinal and hepatic manifestations of Sjogren syndrome. J Clin Gastroenterol 46(1):25\u201330. doi:10.1097\/MCG.0b013e3182329d9c","journal-title":"J Clin Gastroenterol"},{"issue":"13","key":"328_CR63","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archinte.158.13.1445","volume":"158","author":"L Fernandez-Soto","year":"1998","unstructured":"Fernandez-Soto L, Gonzalez A, Escobar-Jimenez F, Vazquez R, Ocete E, Olea N, Salmeron J (1998) Increased risk of autoimmune thyroid disease in hepatitis C vs hepatitis B before, during, and after discontinuing interferon therapy. Arch Intern Med 158(13):1445\u20131448","journal-title":"Arch Intern Med"},{"issue":"6","key":"328_CR64","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.1840200650","volume":"20","author":"MJ Huang","year":"1994","unstructured":"Huang MJ, Wu SS, Liaw YF (1994) Thyroid abnormalities in patients with chronic viral hepatitis. Hepatology 20(6):1651\u20131652","journal-title":"Hepatology"},{"issue":"5","key":"328_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/eje.0.1320587","volume":"132","author":"D Preziati","year":"1995","unstructured":"Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P (1995) Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 132(5):587\u2013593","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"328_CR66","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0168-8278(05)80022-4","volume":"18","author":"JF Quaranta","year":"1993","unstructured":"Quaranta JF, Tran A, Regnier D, Letestu R, Beusnel C, Fuzibet JG, Thiers V, Rampal P (1993) High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol 18(1):136\u2013138","journal-title":"J Hepatol"},{"issue":"6","key":"328_CR67","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M, Garcia-Buey L, Gonzalez-Fernandez B, Garcia-Monzon C, Arranz A, Borque MJ, Moreno-Otero R (1996) Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxf) 44(6):635\u2013642","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"328_CR68","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/hep.510260127","volume":"26","author":"M Deutsch","year":"1997","unstructured":"Deutsch M, Dourakis S, Manesis EK, Gioustozi A, Hess G, Horsch A, Hadziyannis S (1997) Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology 26(1):206\u2013210. doi:10.1002\/hep.510260127","journal-title":"Hepatology"},{"issue":"1","key":"328_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","volume":"117","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117(1):10\u201313. doi:10.1016\/j.amjmed.2004.01.023S0002934304002062","journal-title":"Am J Med"},{"issue":"9","key":"328_CR70","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/BF03343626","volume":"22","author":"A Loviselli","year":"1999","unstructured":"Loviselli A, Oppo A, Velluzzi F, Atzeni F, Mastinu GL, Farci P, Orgiana G, Balestrieri A, Cocco PL, Mariotti S (1999) Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia. J Endocrinol Invest 22(9):660\u2013665","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"328_CR71","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/thy.2006.16.563","volume":"16","author":"A Antonelli","year":"2006","unstructured":"Antonelli A, Ferri C, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E (2006) Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16(6):563\u2013572. doi:10.1089\/thy.2006.16.563","journal-title":"Thyroid"},{"issue":"6","key":"328_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/105072503322238809","volume":"13","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Laurberg P (2003) Interferon-alpha and autoimmune thyroid disease. Thyroid 13(6):547\u2013551. doi:10.1089\/105072503322238809","journal-title":"Thyroid"},{"issue":"5","key":"328_CR73","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.2337\/dc05-1995","volume":"29","author":"A Lecube","year":"2006","unstructured":"Lecube A, Hernandez C, Genesca J, Simo R (2006) Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care 29(5):1140\u20131149. doi:10.2337\/diacare.2951140","journal-title":"Diabetes Care"},{"issue":"8818","key":"328_CR74","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0140-6736(92)91744-S","volume":"340","author":"P Fabris","year":"1992","unstructured":"Fabris P, Betterle C, Floreani A, Greggio NA, de Lazzari F, Naccarato R, Chiaramonte M (1992) Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis [letter] [see comments]. Lancet 340(8818):548","journal-title":"Lancet"},{"issue":"1","key":"328_CR75","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12016-007-8013-6","volume":"34","author":"R Maya","year":"2008","unstructured":"Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34(1):85\u2013102. doi:10.1007\/s12016-007-8013-6","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"328_CR76","first-page":"469","volume":"15","author":"GB di Belgiojoso","year":"2002","unstructured":"di Belgiojoso GB, Ferrario F, Landriani N (2002) Virus-related glomerular diseases: histological and clinical aspects. J Nephrol 15(5):469\u2013479","journal-title":"J Nephrol"},{"issue":"6","key":"328_CR77","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.semarthrit.2003.10.001","volume":"33","author":"C Ferri","year":"2004","unstructured":"Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C, Zignego AL (2004) Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33(6):355\u2013374","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"328_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.rdc.2009.03.006","volume":"35","author":"P Cacoub","year":"2009","unstructured":"Cacoub P, Terrier B (2009) Hepatitis B-related autoimmune manifestations. Rheum Dis Clin North Am 35(1):125\u2013137. doi:10.1016\/j.rdc.2009.03.006","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"328_CR79","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/hep.510240309","volume":"24","author":"GV Gregorio","year":"1996","unstructured":"Gregorio GV, Jones H, Choudhuri K, Vegnente A, Bortolotti F, Mieli-Vergani G, Vergani D (1996) Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa. Hepatology 24(3):520\u2013523. doi:10.1002\/hep.510240309","journal-title":"Hepatology"},{"issue":"26","key":"328_CR80","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJM197706302962605","volume":"296","author":"Y Levo","year":"1977","unstructured":"Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC (1977) Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 296(26):1501\u20131504. doi:10.1056\/NEJM197706302962605","journal-title":"N Engl J Med"},{"issue":"4","key":"328_CR81","first-page":"209","volume":"7","author":"M Galli","year":"1992","unstructured":"Galli M, Monti G, Invernizzi F, Monteverde A, Bombardieri S, Gabrielli A, Migliaresi S, Mussini C, Ossi E, Pietrogrande M et al (1992) Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. The Italian Group for the Study of Cryoglobulinemias (GISC). Ann Ital Med Int 7(4):209\u2013214","journal-title":"Ann Ital Med Int"},{"issue":"3","key":"328_CR82","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ki.1984.178","volume":"26","author":"H Hirose","year":"1984","unstructured":"Hirose H, Udo K, Kojima M, Takahashi Y, Miyakawa Y, Miyamoto K, Yoshizawa H, Mayumi M (1984) Deposition of hepatitis B e antigen in membranous glomerulonephritis: identification by F(ab')2 fragments of monoclonal antibody. Kidney Int 26(3):338\u2013341","journal-title":"Kidney Int"},{"key":"328_CR83","first-page":"S5","volume":"35","author":"RJ Glassock","year":"1991","unstructured":"Glassock RJ (1991) Immune complex-induced glomerular injury in viral diseases: an overview. Kidney Int Suppl 35:S5\u2013S7","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"328_CR84","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/0016-5085(95)90343-7","volume":"109","author":"HS Conjeevaram","year":"1995","unstructured":"Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM (1995) Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109(2):540\u2013546","journal-title":"Gastroenterology"},{"issue":"4","key":"328_CR85","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1523-1755.2005.00591.x","volume":"68","author":"S Tang","year":"2005","unstructured":"Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN (2005) Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68(4):1750\u20131758. doi:10.1111\/j.1523-1755.2005.00591.x","journal-title":"Kidney Int"},{"issue":"36","key":"328_CR86","first-page":"1575","volume":"78","author":"C Trepo","year":"1970","unstructured":"Trepo C, Thivolet J (1970) Australia antigen, virus hepatitis and periarteritis nodosa. Presse Med 78(36):1575","journal-title":"Presse Med"},{"issue":"7684","key":"328_CR87","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(70)90339-9","volume":"2","author":"DJ Gocke","year":"1970","unstructured":"Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL (1970) Association between polyarteritis and Australia antigen. Lancet 2(7684):1149\u20131153","journal-title":"Lancet"},{"issue":"5","key":"328_CR88","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.md.0000180792.80212.5e","volume":"84","author":"L Guillevin","year":"2005","unstructured":"Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84(5):313\u2013322","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"328_CR89","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/art.27240","volume":"62","author":"C Pagnoux","year":"2010","unstructured":"Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62(2):616\u2013626. doi:10.1002\/art.27240","journal-title":"Arthritis Rheum"},{"issue":"3","key":"328_CR90","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/art.20401","volume":"51","author":"L Guillevin","year":"2004","unstructured":"Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, Hausfater P, Roudier J, Bielefeld P, Petitjean P, Smadja D (2004) Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 51(3):482\u2013487. doi:10.1002\/art.20401","journal-title":"Arthritis Rheum"},{"issue":"5","key":"328_CR91","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/ard.53.5.334","volume":"53","author":"L Guillevin","year":"1994","unstructured":"Guillevin L, Lhote F, Sauvaget F, Deblois P, Rossi F, Levallois D, Pourrat J, Christoforov B, Trepo C (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53(5):334\u2013337","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"328_CR92","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1136\/adc.48.10.794","volume":"48","author":"F Gianotti","year":"1973","unstructured":"Gianotti F (1973) Papular acrodermatitis of childhood. An Australia antigen disease. Arch Dis Child 48(10):794\u2013799","journal-title":"Arch Dis Child"},{"issue":"1","key":"328_CR93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-89-1-34","volume":"89","author":"JL Dienstag","year":"1978","unstructured":"Dienstag JL, Rhodes AR, Bhan AK, Dvorak AM, Mihm MC Jr, Wands JR (1978) Urticaria associated with acute viral hepatitis type B: studies of pathogenesis. Ann Intern Med 89(1):34\u201340","journal-title":"Ann Intern Med"},{"issue":"1","key":"328_CR94","first-page":"80","volume":"78","author":"MJ Amengual","year":"1989","unstructured":"Amengual MJ, Catalfamo M, Pujol A, Juarez C, Gelpi C, Rodriguez JL (1989) Autoantibodies in chronic delta virus infection recognize a common protein of 46\u00a0kD in rat forestomach basal cell layer and stellate thymic epithelial cells. Clin Exp Immunol 78(1):80\u201384","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"328_CR95","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/hep.1840040601","volume":"4","author":"D Zauli","year":"1984","unstructured":"Zauli D, Fusconi M, Crespi C, Bianchi FB, Craxi A, Pisi E (1984) Close association between basal cell layer antibodies and hepatitis B virus-associated chronic delta infection. Hepatology 4(6):1103\u20131106","journal-title":"Hepatology"},{"issue":"1","key":"328_CR96","first-page":"232","volume":"54","author":"O Crivelli","year":"1983","unstructured":"Crivelli O, Lavarini C, Chiaberge E, Amoroso A, Farci P, Negro F, Rizzetto M (1983) Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent. Clin Exp Immunol 54(1):232\u2013238","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"328_CR97","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","volume":"111","author":"CP Strassburg","year":"1996","unstructured":"Strassburg CP, Obermayer-Straub P, Alex B, Durazzo M, Rizzetto M, Tukey RH, Manns MP (1996) Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis. Gastroenterology 111(6):1576\u20131586","journal-title":"Gastroenterology"},{"issue":"5","key":"328_CR98","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1053\/jhep.2001.24101","volume":"33","author":"T Bachrich","year":"2001","unstructured":"Bachrich T, Thalhammer T, Jager W, Haslmayer P, Alihodzic B, Bakos S, Hitchman E, Senderowicz AM, Penner E (2001) Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases. Hepatology 33(5):1053\u20131059. doi:10.1053\/jhep.2001.24101","journal-title":"Hepatology"},{"issue":"5","key":"328_CR99","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/hep.1840120509","volume":"12","author":"J Wesierska-Gadek","year":"1990","unstructured":"Wesierska-Gadek J, Penner E, Hitchman E, Sauermann G (1990) Antibodies to nuclear lamin C in chronic hepatitis delta virus infection. Hepatology 12(5):1129\u20131133","journal-title":"Hepatology"},{"issue":"3660","key":"328_CR100","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.147.3660.824-b","volume":"147","author":"RT Damian","year":"1965","unstructured":"Damian RT (1965) Molecular mimicry in biological adaptation. Science 147(3660):824. doi:10.1126\/science.147.3660.824-b","journal-title":"Science"},{"issue":"6","key":"328_CR101","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0092-8674(87)90507-1","volume":"50","author":"MB Oldstone","year":"1987","unstructured":"Oldstone MB (1987) Molecular mimicry and autoimmune disease. Cell 50(6):819\u2013820","journal-title":"Cell"},{"issue":"4","key":"328_CR102","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","volume":"21","author":"DP Bogdanos","year":"2001","unstructured":"Bogdanos DP, Choudhuri K, Vergani D (2001) Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences. Liver 21(4):225\u2013232","journal-title":"Liver"},{"issue":"2","key":"328_CR103","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nri724","volume":"2","author":"CL Vanderlugt","year":"2002","unstructured":"Vanderlugt CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol 2(2):85\u201395. doi:10.1038\/nri724","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"328_CR104","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","volume":"3","author":"L Muratori","year":"2005","unstructured":"Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Mieli-Vergani G, Bianchi FB, Vergani D (2005) Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 3(6):595\u2013603","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"328_CR105","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.4049\/jimmunol.162.3.1802","volume":"162","author":"GV Gregorio","year":"1999","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Vegnente A, Mieli-Vergani G, Vergani D (1999) Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection. J Immunol 162(3):1802\u20131810","journal-title":"J Immunol"},{"issue":"3","key":"328_CR106","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","volume":"133","author":"GV Gregorio","year":"2003","unstructured":"Gregorio GV, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P, Garson J, Bogdanos DP, Vegnente A, Mieli-Vergani G, Vergani D (2003) Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol 133(3):404\u2013413","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"328_CR107","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1172\/JCI115443","volume":"88","author":"MP Manns","year":"1991","unstructured":"Manns MP, Griffin KJ, Sullivan KF, Johnson EF (1991) LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 88(4):1370\u20131378","journal-title":"J Clin Invest"},{"issue":"1","key":"328_CR108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","volume":"17","author":"DP Bogdanos","year":"2004","unstructured":"Bogdanos DP, Lenzi M, Okamoto M, Rigopoulou EI, Muratori P, Ma Y, Muratori L, Tsantoulas D, Mieli-Vergani G, Bianchi FB, Vergani D (2004) Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51. Int J Immunopathol Pharmacol 17(1):83\u201392","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"328_CR109","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","volume":"130","author":"Y Ma","year":"2006","unstructured":"Ma Y, Bogdanos DP, Hussain MJ, Underhill J, Bansal S, Longhi MS, Cheeseman P, Mieli-Vergani G, Vergani D (2006) Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2. Gastroenterology 130(3):868\u2013882. doi:10.1053\/j.gastro.2005.12.020","journal-title":"Gastroenterology"},{"issue":"4","key":"328_CR110","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/gut.46.4.553","volume":"46","author":"L Muratori","year":"2000","unstructured":"Muratori L, Parola M, Ripalti A, Robino G, Muratori P, Bellomo G, Carini R, Lenzi M, Landini MP, Albano E, Bianchi FB (2000) Liver\/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut 46(4):553\u2013561","journal-title":"Gut"},{"issue":"19","key":"328_CR111","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1365-2893.2011.01578.x","volume":"2012","author":"F Girardin","year":"2012","unstructured":"Girardin F, Daali Y, Gex-Fabry M, Rebsamen M, Roux-Lombard P, Cerny A, Bihl F, Binek J, Negro F, Desmeules J (2012) Liver kidney microsomes type 1 antibodies are associated with a six-fold reduction of the CYP2D6 activity in patients with chronic hepatitis C. J Viral Hepat 2012; 19: 568-573","journal-title":"J Viral Hepat"},{"issue":"6","key":"328_CR112","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0016-5085(94)90426-X","volume":"106","author":"FD Mackie","year":"1994","unstructured":"Mackie FD, Peakman M, Yun M, Sallie R, Smith H, Davies ET, Mieli-Vergani G, Vergani D (1994) Primary and secondary liver\/kidney microsomal autoantibody response following infection with hepatitis C virus. Gastroenterology 106(6):1672\u20131675","journal-title":"Gastroenterology"},{"key":"328_CR113","doi-asserted-by":"publisher","first-page":"S169","DOI":"10.1097\/00005176-200406001-00419","volume":"39","author":"DP Bogdanos","year":"2004","unstructured":"Bogdanos DP, Ma Y, Hadzic N, Portmann B, Mieli-Vergani G, Vergani D (2004) Virus-self crossreactivity inducing de novo autoimmune hepatitis eight-years after liver transplantation. J Pediatr Gastroenterol Nutr 39:S169","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"328_CR114","first-page":"643","volume":"33","author":"H Hartmann","year":"1995","unstructured":"Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, Pardowitz I, Ramadori G (1995) Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol 33(11):643\u2013650","journal-title":"Z Gastroenterol"},{"issue":"5","key":"328_CR115","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133(5):775\u2013787. doi:10.1016\/j.cell.2008.05.009","journal-title":"Cell"},{"issue":"6","key":"328_CR116","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nri821","volume":"2","author":"EM Shevach","year":"2002","unstructured":"Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2(6):389\u2013400. doi:10.1038\/nri821","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"328_CR117","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D (2004) Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 41(1):31\u201337. doi:10.1016\/j.jhep.2004.03.008","journal-title":"J Hepatol"},{"issue":"12","key":"328_CR118","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","volume":"10","author":"JH Buckner","year":"2010","unstructured":"Buckner JH (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10(12):849\u2013859. doi:10.1038\/nri2889","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"328_CR119","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ijc.25791","volume":"129","author":"Z Shenghui","year":"2011","unstructured":"Shenghui Z, Yixiang H, Jianbo W, Kang Y, Laixi B, Yan Z, Xi X (2011) Elevated frequencies of CD4 CD25 CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer 129(6):1373\u20131381. doi:10.1002\/ijc.25791","journal-title":"Int J Cancer"},{"issue":"5","key":"328_CR120","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/hep.20454","volume":"40","author":"R Cabrera","year":"2004","unstructured":"Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR (2004) An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40(5):1062\u20131071. doi:10.1002\/hep.20454","journal-title":"Hepatology"},{"issue":"9","key":"328_CR121","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/gut.2006.099887","volume":"55","author":"A Perrella","year":"2006","unstructured":"Perrella A, Vitiello L, Atripaldi L, Conti P, Sbreglia C, Altamura S, Patarino T, Vela R, Morelli G, Bellopede P, Alone C, Racioppi L, Perrella O (2006) Elevated CD4+\/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution. Gut 55(9):1370\u20131371. doi:10.1136\/gut.2006.099887","journal-title":"Gut"},{"issue":"12","key":"328_CR122","doi-asserted-by":"publisher","first-page":"7852","DOI":"10.1128\/JVI.79.12.7852-7859.2005","volume":"79","author":"SM Rushbrook","year":"2005","unstructured":"Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P, Alexander GJ (2005) Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79(12):7852\u20137859. doi:10.1128\/JVI.79.12.7852-7859.2005","journal-title":"J Virol"},{"issue":"9","key":"328_CR123","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1182\/blood-2003-07-2598","volume":"103","author":"O Boyer","year":"2004","unstructured":"Boyer O, Saadoun D, Abriol J, Dodille M, Piette JC, Cacoub P, Klatzmann D (2004) CD4 + CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103(9):3428\u20133430. doi:10.1182\/blood-2003-07-2598 2003-07-2598","journal-title":"Blood"},{"issue":"22","key":"328_CR124","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","volume":"365","author":"D Saadoun","year":"2011","unstructured":"Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365(22):2067\u20132077. doi:10.1056\/NEJMoa1105143","journal-title":"N Engl J Med"},{"issue":"4","key":"328_CR125","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2893.2009.01081.x","volume":"16","author":"N Alatrakchi","year":"2009","unstructured":"Alatrakchi N, Koziel M (2009) Regulatory T cells and viral liver disease. J Viral Hepat 16(4):223\u2013229. doi:10.1111\/j.1365-2893.2009.01081.x","journal-title":"J Viral Hepat"},{"issue":"1","key":"328_CR126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.167.1.21","volume":"167","author":"V Racanelli","year":"2001","unstructured":"Racanelli V, Sansonno D, Piccoli C, D'Amore FP, Tucci FA, Dammacco F (2001) Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 167(1):21\u201329","journal-title":"J Immunol"},{"issue":"7","key":"328_CR127","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.160.7.3594","volume":"160","author":"D Sansonno","year":"1998","unstructured":"Sansonno D, De Vita S, Iacobelli AR, Cornacchiulo V, Boiocchi M, Dammacco F (1998) Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 160(7):3594\u20133601","journal-title":"J Immunol"},{"issue":"21","key":"328_CR128","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","volume":"327","author":"V Agnello","year":"1992","unstructured":"Agnello V, Chung RT, Kaplan LM (1992) A role for hepatitis C virus infection in type II cryoglobulinemia [see comments]. N Engl J Med 327(21):1490\u20131495","journal-title":"N Engl J Med"},{"issue":"3","key":"328_CR129","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2249.2000.01396.x","volume":"122","author":"A Fornasieri","year":"2000","unstructured":"Fornasieri A, Bernasconi P, Ribero ML, Sinico RA, Fasola M, Zhou J, Portera G, Tagger A, Gibelli A, D'Amico G (2000) Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia. Clin Exp Immunol 122(3):400\u2013403","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"328_CR130","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","volume":"77","author":"VM Sung","year":"2003","unstructured":"Sung VM, Shimodaira S, Doughty AL, Picchio GR, Can H, Yen TS, Lindsay KL, Levine AM, Lai MM (2003) Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 77(3):2134\u20132146","journal-title":"J Virol"},{"issue":"2","key":"328_CR131","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2249.2006.03272.x","volume":"147","author":"D Sansonno","year":"2007","unstructured":"Sansonno D, Tucci FA, Lauletta G, De Re V, Montrone M, Troiani L, Sansonno L, Dammacco F (2007) Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia. Clin Exp Immunol 147(2):241\u2013248. doi:10.1111\/j.1365-2249.2006.03272.x","journal-title":"Clin Exp Immunol"},{"issue":"13","key":"328_CR132","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","volume":"98","author":"ER Quinn","year":"2001","unstructured":"Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S (2001) The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98(13):3745\u20133749","journal-title":"Blood"},{"issue":"2","key":"328_CR133","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","volume":"87","author":"V De Re","year":"2000","unstructured":"De Re V, De Vita S, Marzotto A, Gloghini A, Pivetta B, Gasparotto D, Cannizzaro R, Carbone A, Boiocchi M (2000) Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 87(2):211\u2013216. doi:10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","journal-title":"Int J Cancer"},{"issue":"2","key":"328_CR134","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nri1548","volume":"5","author":"S Levy","year":"2005","unstructured":"Levy S, Shoham T (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5(2):136\u2013148. doi:10.1038\/nri1548","journal-title":"Nat Rev Immunol"},{"key":"328_CR135","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.immunol.18.1.393","volume":"18","author":"DT Fearon","year":"2000","unstructured":"Fearon DT, Carroll MC (2000) Regulation of B lymphocyte responses to foreign and self-antigens by the CD19\/CD21 complex. Annu Rev Immunol 18:393\u2013422. doi:10.1146\/annurev.immunol.18.1.393","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"328_CR136","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","volume":"46","author":"D Sene","year":"2007","unstructured":"Sene D, Limal N, Ghillani-Dalbin P, Saadoun D, Piette JC, Cacoub P (2007) Hepatitis C virus-associated B-cell proliferation\u2014the role of serum B lymphocyte stimulator (BLyS\/BAFF). Rheumatology (Oxford) 46(1):65\u201369. doi:10.1093\/rheumatology\/kel177","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"328_CR137","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jaut.2006.07.005","volume":"27","author":"E Toubi","year":"2006","unstructured":"Toubi E, Gordon S, Kessel A, Rosner I, Rozenbaum M, Shoenfeld Y, Zuckerman E (2006) Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 27(2):134\u2013139. doi:10.1016\/j.jaut.2006.07.005","journal-title":"J Autoimmun"},{"issue":"3","key":"328_CR138","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.2007.085910","volume":"68","author":"DA Landau","year":"2009","unstructured":"Landau DA, Rosenzwajg M, Saadoun D, Klatzmann D, Cacoub P (2009) The B lymphocyte stimulator receptor\u2013ligand system in hepatitis C virus-induced B cell clonal disorders. Ann Rheum Dis 68(3):337\u2013344. doi:10.1136\/ard.2007.085910","journal-title":"Ann Rheum Dis"},{"issue":"6430","key":"328_CR139","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1136\/bmj.288.6430.1563","volume":"288","author":"P Pontisso","year":"1984","unstructured":"Pontisso P, Poon MC, Tiollais P, Brechot C (1984) Detection of hepatitis B virus DNA in mononuclear blood cells. Br Med J (Clin Res Ed) 288(6430):1563\u20131566","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"328_CR140","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1349-7006.2002.tb01280.x","volume":"93","author":"JH Kim","year":"2002","unstructured":"Kim JH, Bang YJ, Park BJ, Yoo T, Kim CW, Kim TY, Heo DS, Lee HS, Kim NK (2002) Hepatitis B virus infection and B-cell non-Hodgkin\u2019s lymphoma in a hepatitis B endemic area: a case\u2013control study. Jpn J Cancer Res 93(5):471\u2013477","journal-title":"Jpn J Cancer Res"},{"issue":"4","key":"328_CR141","first-page":"554","volume":"91","author":"F Marcucci","year":"2006","unstructured":"Marcucci F, Mele A, Spada E, Candido A, Bianco E, Pulsoni A, Chionne P, Madonna E, Cotichini R, Barbui A, De Renzo A, Dore F, Iannitto E, Liso V, Martino B, Montanaro M, Pagano L, Musto P, Rapicetta M (2006) High prevalence of hepatitis B virus infection in B-cell non-Hodgkin\u2019s lymphoma. Haematologica 91(4):554\u2013557","journal-title":"Haematologica"},{"issue":"7","key":"328_CR142","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/cncr.22549","volume":"109","author":"F Wang","year":"2007","unstructured":"Wang F, Xu RH, Han B, Shi YX, Luo HY, Jiang WQ, Lin TY, Huang HQ, Xia ZJ, Guan ZZ (2007) High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer 109(7):1360\u20131364. doi:10.1002\/cncr.22549","journal-title":"Cancer"},{"issue":"1","key":"328_CR143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.21642","volume":"46","author":"M Ulcickas Yood","year":"2007","unstructured":"Ulcickas Yood M, Quesenberry CP Jr, Guo D, Caldwell C, Wells K, Shan J, Sanders L, Skovron ML, Iloeje U, Manos MM (2007) Incidence of non-Hodgkin\u2019s lymphoma among individuals with chronic hepatitis B virus infection. Hepatology 46(1):107\u2013112. doi:10.1002\/hep.21642","journal-title":"Hepatology"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-012-0328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00281-012-0328-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-012-0328-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-012-0328-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:27:51Z","timestamp":1687631271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00281-012-0328-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,28]]},"references-count":143,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["328"],"URL":"https:\/\/doi.org\/10.1007\/s00281-012-0328-6","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,28]]},"assertion":[{"value":"3 February 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}